{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:28:25Z","timestamp":1792301305850,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clinthera.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T20:24:04Z","timestamp":1694291044000},"page":"1119-1126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-4076","authenticated-orcid":false,"given":"M. Cecilia","family":"Bahit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Korjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Daaboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Kalayci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Shaunik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.08.011_bib0001","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0002","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.amjcard.2011.02.332","article-title":"Comparison of outcome of recurrent versus first ST-segment elevation myocardial infarction (from national Israel surveys 1998 to 2006)","volume":"107","author":"Shotan","year":"2011","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0003","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0004","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"Collet","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2017","journal-title":"European Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0006","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0007","first-page":"e344","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Non\u2013ST-Elevation Acute Coronary Syndromes","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0008","first-page":"189","article-title":"The challenge of patient adherence","volume":"1","author":"Martin","year":"2005","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0009","first-page":"35","article-title":"Adherence and health care costs","volume":"7","author":"Iuga","year":"2014","journal-title":"Risk Management Healthcare Policy"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value in Health"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"British journal of clinical pharmacology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-3258-72-37","article-title":"Adherence influencing factors\u2013a systematic review of systematic reviews","volume":"72","author":"Mathes","year":"2014","journal-title":"Archives of Public Health"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0013","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042878","article-title":"In-hospital myocardial infarction and adherence to evidence-based drug therapies: a real-world evaluation","volume":"11","author":"Soldati","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","article-title":"Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population","volume":"41","author":"Huber","year":"2019","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to Statin Therapy Among US Adults Between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011448","article-title":"Association of diabetes mellitus status and glycemic control with secondary prevention medication adherence after acute myocardial infarction","volume":"8","author":"Adamek","year":"2019","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0018","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamacardio.2017.0911","article-title":"Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries","volume":"2","author":"Colantonio","year":"2017","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamacardio.2019.4408","article-title":"Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial","volume":"5","author":"Fanaroff","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamacardio.2016.0001","article-title":"Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction","volume":"1","author":"Faridi","year":"2016","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0021","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamainternmed.2013.12944","article-title":"Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial","volume":"174","author":"Ho","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0022","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.117.029160","article-title":"Hospital variation in adherence rates to secondary prevention medications and the implications on quality","volume":"137","author":"Mathews","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2021.03.013","article-title":"Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial","volume":"323","author":"Zafeiropoulos","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0024","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/2047487315597209","article-title":"Determinants of adherence to evidence-based therapy after acute myocardial infarction","volume":"23","author":"Hamood","year":"2016","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCOUTCOMES.109.919415","article-title":"Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge","volume":"3","author":"Bagnall","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0026","first-page":"e25548","article-title":"Efficacy and Safety of Text Messages Targeting Adherence to Cardiovascular Medications in Secondary Prevention: TXT2HEART Colombia Randomized Controlled Trial","volume":"9","author":"Bermon","year":"2021","journal-title":"Journal of Medical Internet Research"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/imj.13736","article-title":"Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study","volume":"48","author":"Brieger","year":"2018","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0028","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1038\/s41598-019-48540-3","article-title":"Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial","volume":"9","author":"Daniel","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ahj.2016.05.005","article-title":"Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study","volume":"178","author":"Johnston","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11096-012-9735-y","article-title":"Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes","volume":"35","author":"Kassab","year":"2013","journal-title":"International Journal of Clinical Pharmacy"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.annepidem.2020.09.016","article-title":"Role of psychosocial factors in long-term adherence to secondary prevention measures after myocardial infarction: a longitudinal analysis","volume":"52","author":"Nachshol","year":"2020","journal-title":"Annals of Epidemiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-016-0283-6","article-title":"Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction","volume":"16","author":"Halvorsen","year":"2016","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183963","article-title":"Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial","volume":"12","author":"Huber","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12240","article-title":"Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study","volume":"35","author":"Cordero","year":"2017","journal-title":"Cardiovascular Therapeutics"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0035","doi-asserted-by":"crossref","unstructured":"Khatib R, et\u00a0al. Adherence to coronary artery disease secondary prevention medicines: Exploring modifiable barriers. Open Heart, 2019. 6 (no pagination) (e000997).","DOI":"10.1136\/openhrt-2018-000997"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01362-y","article-title":"The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: Development and utility","volume":"20","author":"Khatib","year":"2020","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0037","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11606-007-0351-9","article-title":"Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction","volume":"23","author":"Akincigil","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0038","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1532-5415.2009.02483.x","article-title":"Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time","volume":"57","author":"Ali","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40266-014-0189-x","article-title":"Secondary prevention medication after myocardial infarction: Persistence in elderly people over the course of 1 year","volume":"31","author":"Al-Khadra","year":"2014","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0040","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.gheart.2016.03.167","article-title":"Health system barriers to and facilitators of adherence to medications for the secondary prevention of cardiovascular disease: A systematic review","author":"Banerjee","year":"2016","journal-title":"Global Heart"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0041","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1016\/S0735-1097(11)60485-3","article-title":"Is cardiac rehabilitation associated with improved medication persistence following acute myocardial infarction?","author":"Boyden","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0042","first-page":"375","article-title":"One-year persistence and adherence rates to secondary prevention drugs prescribed in-hospital in patients with acute coronary syndromes. The ALASCA Study","author":"Bueno","year":"2010","journal-title":"European Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0043","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"American Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0044","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/heartjnl-2014-306754","article-title":"Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction","volume":"101","author":"Shore","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2017.11.075","article-title":"Polypill, hypertension and medication adherence: The solution strategy?","volume":"252","author":"Cimmaruta","year":"2018","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0046","doi-asserted-by":"crossref","first-page":"m1731","DOI":"10.1136\/bmj.m1731","article-title":"Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial","volume":"369","author":"Ivers","year":"2020","journal-title":"BMJ"},{"issue":"3 Supplement","key":"10.1016\/j.clinthera.2023.08.011_bib0047","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2047487317708145","article-title":"Improving adherence to medication for secondary cardiovascular disease prevention","volume":"24","author":"Keenan","year":"2017","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2011.12.017","article-title":"Effects of Depression and Anxiety Improvement on Adherence to Medication and Health Behaviors in Recently Hospitalized Cardiac Patients","author":"Bauer","year":"2012","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0049","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijnss.2017.06.007","article-title":"The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction","volume":"4","author":"Al-Smadi","year":"2017","journal-title":"International Journal of Nursing Sciences"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012604","article-title":"Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: A nationwide cohort study from Finland","volume":"6","author":"Prami","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0051","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-018-0707-0","article-title":"Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System","volume":"20","author":"Levy","year":"2018","journal-title":"Current Atherosclerosis Reports"},{"issue":"2 Supplement 1","key":"10.1016\/j.clinthera.2023.08.011_bib0052","first-page":"S128","article-title":"Early follow-up after acute coronary syndrome (ACS) treated with percutaneous coronary intervention: Effect on medication adherence and knowledge of the disease","volume":"25","author":"Elio Venturini","year":"2018","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0053","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019463","article-title":"TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol","volume":"8","author":"Chow","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0054","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCULATIONAHA.121.056161","article-title":"Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial","volume":"145","author":"Chow","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0055","first-page":"1202","article-title":"Effects of interactive patient support with a smartphone app on drug adherence and lifestyle changes in myocardial infarction patients","author":"Varenhorst","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0056","series-title":"Adherence to long-term therapies\u202f: evidence for action","year":"2003"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0057","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.2147\/IJGM.S376926","article-title":"The Association Between Medication Non-Adherence and Early and Late Readmission Rates for Patients with Acute Coronary Syndrome","volume":"15","author":"Murad","year":"2022","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863876","article-title":"Assessing Concurrent Adherence to Combined Essential Medication and Clinical Outcomes in Patients With Acute Coronary Syndrome. A Population-Based, Real-World Study Using Group-Based Trajectory Models","volume":"9","author":"Rodriguez-Bernal","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0059","first-page":"2197","article-title":"Polypill Strategy in Secondary Cardiovascular Prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"Reply. New England Journal of Medicine"},{"key":"10.1016\/j.clinthera.2023.08.011_bib0060","first-page":"9","article-title":"Medication-taking for secondary prevention of acute myocardial infarction: a thematic meta-synthesis of patient experiences","author":"Piekarz","year":"2022","journal-title":"Open Heart"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:00:37Z","timestamp":1758963637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823003144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0149291823003144"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.08.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}